Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision

MT Newswires Live

08/21

Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.

The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.

Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2561467622"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561467622\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561467622?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561467622","market":"hk","top_or_hot":-1,"title":"Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.</p><p>The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.</p><p>Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-08-21 20:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.</p><p>The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.</p><p>Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2561467622","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561467622","pubTimestamp":1755777678,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Haohai Biological Technology  expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688366":"昊海生科","BK1161":"生物科技","BK1593":"医美概念股","06826":"昊海生物科技","BK0251":"专用设备","BK0239":"医药制造"},"translate_title":"昊海生科终止收购恒泰视界计划后将获得8000万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688366":0.9,"06826":0.9},"content_text":"Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}